PL3082762T3 - Kompozycje ketoprofenowe o długim działaniu - Google Patents

Kompozycje ketoprofenowe o długim działaniu

Info

Publication number
PL3082762T3
PL3082762T3 PL14827320T PL14827320T PL3082762T3 PL 3082762 T3 PL3082762 T3 PL 3082762T3 PL 14827320 T PL14827320 T PL 14827320T PL 14827320 T PL14827320 T PL 14827320T PL 3082762 T3 PL3082762 T3 PL 3082762T3
Authority
PL
Poland
Prior art keywords
long
ketoprofen compositions
acting
acting ketoprofen
compositions
Prior art date
Application number
PL14827320T
Other languages
English (en)
Inventor
Richard Andrew Ewin
Steven X. Hu
Susan M. Machkovech
Barton H. Manning
Stephen Lee Secreast
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52347413&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3082762(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of PL3082762T3 publication Critical patent/PL3082762T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL14827320T 2013-12-16 2014-12-15 Kompozycje ketoprofenowe o długim działaniu PL3082762T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361916462P 2013-12-16 2013-12-16
EP14827320.4A EP3082762B1 (en) 2013-12-16 2014-12-15 Long-acting ketoprofen compositions
PCT/US2014/070336 WO2015095045A1 (en) 2013-12-16 2014-12-15 Long-acting ketoprofen compositions

Publications (1)

Publication Number Publication Date
PL3082762T3 true PL3082762T3 (pl) 2022-02-14

Family

ID=52347413

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14827320T PL3082762T3 (pl) 2013-12-16 2014-12-15 Kompozycje ketoprofenowe o długim działaniu

Country Status (16)

Country Link
US (1) US10632095B2 (pl)
EP (1) EP3082762B1 (pl)
JP (2) JP6306188B2 (pl)
KR (1) KR101817028B1 (pl)
CN (2) CN112843042A (pl)
AU (1) AU2014366221C1 (pl)
CA (1) CA2931858C (pl)
CL (1) CL2016001350A1 (pl)
DK (1) DK3082762T3 (pl)
ES (1) ES2901706T3 (pl)
MX (1) MX2016007869A (pl)
NZ (1) NZ719783A (pl)
PH (1) PH12016500910A1 (pl)
PL (1) PL3082762T3 (pl)
RU (1) RU2646829C1 (pl)
WO (1) WO2015095045A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082762B1 (en) * 2013-12-16 2021-11-17 Zoetis Services LLC Long-acting ketoprofen compositions
US9714403B2 (en) 2014-06-19 2017-07-25 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
AU2018382217B2 (en) * 2017-12-11 2024-03-28 Meat & Livestock Australia Ltd Transdermal analgesic formulation
US20210315846A1 (en) * 2018-08-24 2021-10-14 Centrexion Therspeuties Corporation Capsaicin sequential dosing method for treatment of knee joint pain
CN115252625B (zh) * 2022-08-11 2024-01-26 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种环维黄杨星d在制备治疗非洲猪瘟的制剂中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1709232A (en) * 1927-12-19 1929-04-16 James J Richardson Steering mechanism
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
US4560785A (en) 1983-03-02 1985-12-24 Ss Pharmaceutical Co., Ltd. Phenylacetic ester derivatives and process for preparing the same
DE3324193A1 (de) 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg Depot-antiphlogistika
US6217911B1 (en) * 1995-05-22 2001-04-17 The United States Of America As Represented By The Secretary Of The Army sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
GB9118149D0 (en) * 1991-08-22 1991-10-09 Enzymatix Ltd Araylalkanoic acid resolution
KR100499438B1 (ko) * 1997-12-03 2005-07-07 머크 앤드 캄파니 인코포레이티드 수소화 피마자유를 함유하는 지속성 주사제
WO1999052528A1 (en) * 1998-04-11 1999-10-21 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
CN1709232A (zh) * 2005-06-15 2005-12-21 沈阳药科大学 含有酮洛芬或酮洛芬酯的注射用脂质微球及其制备工艺
EP2089007A2 (en) * 2006-10-27 2009-08-19 Noven Pharmaceuticals, INC. Transdermal delivery of ketoprofen polar derivatives
US20100125060A1 (en) * 2008-11-19 2010-05-20 Majid Razzak Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
FR2950533B1 (fr) 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
CN102648897A (zh) * 2012-04-28 2012-08-29 东华大学 一种酮洛芬高分子前药聚合物微球及其制备方法
EP3082762B1 (en) * 2013-12-16 2021-11-17 Zoetis Services LLC Long-acting ketoprofen compositions

Also Published As

Publication number Publication date
CA2931858C (en) 2018-12-11
CL2016001350A1 (es) 2016-11-25
AU2014366221B2 (en) 2019-06-13
NZ719783A (en) 2017-01-27
KR20160078491A (ko) 2016-07-04
US20160303065A1 (en) 2016-10-20
US10632095B2 (en) 2020-04-28
KR101817028B1 (ko) 2018-01-09
BR112016012235A2 (pt) 2017-08-08
EP3082762B1 (en) 2021-11-17
RU2016121639A (ru) 2018-01-23
JP2018058880A (ja) 2018-04-12
JP6306188B2 (ja) 2018-04-04
EP3082762A1 (en) 2016-10-26
RU2646829C1 (ru) 2018-03-07
CN105848638A (zh) 2016-08-10
CA2931858A1 (en) 2015-06-25
BR112016012235A8 (pt) 2018-01-30
DK3082762T3 (da) 2021-12-06
CN112843042A (zh) 2021-05-28
AU2014366221C1 (en) 2019-10-03
JP2016539997A (ja) 2016-12-22
AU2014366221A1 (en) 2016-05-26
ES2901706T3 (es) 2022-03-23
PH12016500910A1 (en) 2016-06-20
MX2016007869A (es) 2016-10-07
WO2015095045A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
HK1223270A1 (zh) 長效螺異惡唑啉製劑
PL3065569T4 (pl) Kompozycja
GB201304662D0 (en) Compositions
EP2889350A4 (en) ADHESIVE COMPOSITION
PL2968214T3 (pl) Nowe kompozycje przeciwbólowe
GB201313615D0 (en) Compositions
HK1214088A1 (zh) 油脂組合物
HUE044039T2 (hu) Biokatalitikus készítmény
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322772D0 (en) Composition
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
PL3082762T3 (pl) Kompozycje ketoprofenowe o długim działaniu
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
ZA201505650B (en) New compositions
GB201420672D0 (en) Composition
GB201308502D0 (en) Composition
GB201301774D0 (en) Composition
GB201320962D0 (en) Compositions